Anticholinergic burden in Parkinson's disease inpatients.
about
Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease.Parkinson's Disease: From Pathogenesis to PharmacogenomicsAtropinic (Anticholinergic) Burden in Parkinson's Disease.Anticholinergic burden and health outcomes among older adults discharged from hospital: results from the CRIME study.Neuroprotective Effects and Mechanisms of Action of Multifunctional Agents Targeting Free Radicals, Monoamine Oxidase B and Cholinesterase in Parkinson's Disease Model.Anticholinergic Burden and Most Common Anticholinergic-acting Medicines in Older General Practice Patients.
P2860
Anticholinergic burden in Parkinson's disease inpatients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Anticholinergic burden in Parkinson's disease inpatients.
@en
type
label
Anticholinergic burden in Parkinson's disease inpatients.
@en
prefLabel
Anticholinergic burden in Parkinson's disease inpatients.
@en
P2093
P2860
P1476
Anticholinergic burden in Parkinson's disease inpatients.
@en
P2093
Arantxazu Isla
Javier Peral-Aguirregoitia
Juan Medrano
Rafael Hernandez
Saioa Domingo-Echaburu
P2860
P2888
P304
P356
10.1007/S00228-015-1919-7
P577
2015-08-09T00:00:00Z
P5875
P6179
1011982130